High density lipoprotein changes during treatment of diabetic ketoacidosis

Diabete Metab. 1985 Apr;11(2):102-5.

Abstract

Serum concentration of apoprotein A, high density lipoprotein (HDL)-cholesterol and HDL-phospholipids has been studied in thirteen consecutive episodes of diabetic ketoacidosis. In three patients with type I diabetes mellitus HDL2 and HDL3 subfractions were also measured. Patients with type I diabetes showed greatly decreased HDL-cholesterol concentration on admission which increased into the normal range after insulin treatment, while HDL-phospholipids decreased during treatment and apoprotein A remained almost unmodified. In three patients with type I diabetes a virtual absence of HDL2-cholesterol subfraction was observed, which rose to normal values during recovery. Conversely, in type II diabetes mellitus HDL-cholesterol was slightly reduced on admission, and tended to decrease during recovery. These findings imply the existence of abnormalities in the qualitative composition of HDL, and indicate that HDL-cholesterol can fluctuate much more rapidly than previously thought.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Apolipoproteins A / blood
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Chylomicrons / blood
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 2 / blood
  • Diabetic Ketoacidosis / blood*
  • Diabetic Ketoacidosis / drug therapy
  • Female
  • Humans
  • Insulin / therapeutic use
  • Kinetics
  • Lipoproteins, HDL / blood*
  • Male
  • Middle Aged
  • Phospholipids / blood
  • Triglycerides / blood

Substances

  • Apolipoproteins A
  • Cholesterol, HDL
  • Chylomicrons
  • Insulin
  • Lipoproteins, HDL
  • Phospholipids
  • Triglycerides
  • Cholesterol